Search Results
News Release
NIH researchers have identified a treatment that significantly decreases the risk of stroke in children with a rare genetic disease called Deficiency of Adenosine Deaminase Type 2 (DADA2).
Staff
Abdel Elkahloun is an associate investigator in NHGRI's Office of Scientific Core Facilities.
… University of Michigan for the study of sarcomas and solid tumors and then joined the National Human Genome Research …
Research Funding
IGNITE enhances genomic medicine by supporting the development of methods for incorporating genomic information into clinical care.
News Release
How well cancer patients fare after chemotherapy can be affected by their social interaction with other patients during treatment.
News Release
Daniel Kastner, M.D., Ph.D., Scientific Director for the Intramural Research Program at the National Human Genome Research Institute (NHGRI) recognized for his pioneering work on the genomics of autoinflammatory diseases.
Genetic Disorders
Skin cancer is the most common type of cancer in the United States.
News Release
A repurposed cancer drug appears to reduce the severity of lesions and pain experienced by people with Proteus syndrome
… worsens with age and increases patients' susceptibility to tumors. Some symptoms can be managed with surgery, but there …
News Release
Genomic analyses turned up genes that belong to inflammatory pathways.
News Release
Genomicists and clinicians are beginning to offer patients genetic testing for a list of treatable diseases apart from the one that brought them into the clinic.
… including up to a 95% chance of thyroid cancer and tumors in the thyroid area. While the tumors are not always cancerous, they can cause painful …
The Genomics Landscape
In the September 2019 edition of The Genomics Landscape, NHGRI Director Eric Green details the American Society of Human Genetics' (ASHG) new strategic plan, which aims to get people everywhere to realize the benefits of genomics and genetics research.